ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,529Medicare Part D Prescriptions Filled, Including Refills

Rank: 536 out of 2343

$491K Total Retail Price of All Prescriptions

Rank: 694 out of 2343

684 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 684 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 684 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,645 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 558 458 1 1
LISINOPRIL 379 313 2 3
LEVOTHYROXINE SODIUM 335 259 3 2
FUROSEMIDE 319 270 4 6
AMLODIPINE BESYLATE 244 213 5 5
OMEPRAZOLE 223 196 6 4
WARFARIN SODIUM 198 185 7 8
METOPROLOL TARTRATE 186 169 8 7
SERTRALINE HCL 183 136 9 20
METFORMIN HCL 172 104 10 9
CARVEDILOL 134 118 11 27
HYDROCODONE-ACETAMINOPHEN 124 89 S3 12 13
POTASSIUM CHLORIDE 124 104 12 18
HYDROCHLOROTHIAZIDE 120 110 14 11
METOPROLOL SUCCINATE 119 108 15 14
CITALOPRAM HBR 117 103 16 17
BENAZEPRIL HCL 113 97 17 113
ATENOLOL 112 94 18 12
DOXAZOSIN MESYLATE 107 105 19 98
PREDNISONE 99 84 20 37
ZOLPIDEM TARTRATE 93 92 21 24
FLUTICASONE PROPIONATE 92 79 22 46
TAMSULOSIN HCL 92 75 22 29
ATORVASTATIN CALCIUM 81 59 24 10
ALLOPURINOL 81 63 24 31
NEXIUM 80 68 26 33
ADVAIR DISKUS 80 63 26 34
ROPINIROLE HCL 80 61 26 124
TRAMADOL HCL 79 67 29 25
CLOPIDOGREL 77 66 30 26
LOVASTATIN 73 61 31 47
JANTOVEN 73 73 31 81
DONEPEZIL HCL 72 72 33 21
GABAPENTIN 71 43 34 16
LOSARTAN-HYDROCHLOROTHIAZIDE 70 66 35 64
AZITHROMYCIN 68 55 36 39
OXYCODONE-ACETAMINOPHEN 63 38 S2 37 49
PROMETHAZINE HCL 61 33 R 38 222
DIOVAN 60 57 39 23
VENLAFAXINE HCL ER 56 50 40 87
SPIRONOLACTONE 55 52 41 65
JANUVIA 54 35 42 50
CRESTOR 53 38 43 30
LOSARTAN POTASSIUM 53 37 43 19
MORPHINE SULFATE ER 53 12 S2 43 142
ESCITALOPRAM OXALATE 53 40 43 55
LANTUS 52 28 47 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 41 48 42
PLAVIX 51 43 48 38
NAMENDA 50 50 50 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.